oral poliovirus vaccine (OPV)

GPTKB entity

Statements (50)
Predicate Object
gptkbp:instance_of gptkb:vaccine
gptkbp:administered_by gptkb:children
national immunization days
other childhood vaccines
gptkbp:associated_with gptkb:virus
community immunity
gptkbp:available_in liquid form
gptkbp:can_cause vaccine-associated paralytic poliomyelitis (VAPP) in rare cases
gptkbp:clinical_trial extensively tested
gptkbp:community_health significantly reduced polio cases
gptkbp:contributes_to herd immunity
gptkbp:developed_by gptkb:Albert_Bruce_Sabin
gptkbp:dosage_form multiple doses required
gptkbp:elimination_status polio eradication efforts
gptkbp:financial_stability stable at room temperature
gptkbp:first_introduced gptkb:1961
gptkbp:formulation drops
gptkbp:global_presence widely used in developing countries
gptkbp:has_been subject of extensive research
https://www.w3.org/2000/01/rdf-schema#label oral poliovirus vaccine (OPV)
gptkbp:influenced_by public health policies
gptkbp:introduced_in many countries during the 1960s
gptkbp:is_available_in developing countries
gptkbp:is_considered a key tool in polio eradication efforts
gptkbp:is_effective_against high
non-polio enteroviruses
wild poliovirus types 1, 2, and 3
gptkbp:is_monitored_by post-vaccination surveillance
gptkbp:is_part_of national immunization programs
WHO's Expanded Programme on Immunization (EPI)
gptkbp:is_recommended_by gptkb:World_Health_Organization
gptkbp:is_recommended_for children under 5 years old
gptkbp:is_used_in countries with polio eradication status
gptkbp:manufacturer various pharmaceutical companies
gptkbp:part_of gptkb:Global_Polio_Eradication_Initiative
gptkbp:replaced_by inactivated poliovirus vaccine (IPV) in some countries
gptkbp:requires trained healthcare personnel for administration
cold chain for distribution
gptkbp:route_of_administration oral
gptkbp:safety_features generally safe
gptkbp:side_effect rarely causes mild gastrointestinal symptoms
gptkbp:storage requires refrigeration
gptkbp:successor inactivated poliovirus vaccine (IPV) in some regions
gptkbp:suitable_for immunocompromised individuals
gptkbp:targets gptkb:poliomyelitis
gptkbp:type live attenuated vaccine
gptkbp:used_in mass immunization campaigns
routine immunization schedules
gptkbp:bfsParent gptkb:poliomyelitis
gptkbp:bfsLayer 5